With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.
CGD Policy Blogs
Using our net health impact calculator and the limited publicly available data to guide the analysis, we find that Ethiopia likely faces significant excess non-COVID-19 deaths in the coming months—possibly more than the COVID-19 deaths avoided by the government’s robust response to the pandemic.
Because of the uncertainties that complicate modelling, there is value in different research groups working independently to build models. Different models will employ different methods, data, and assumptions and will seek to answer different policy questions. Here we take a look from an end-user’s perspective at what models can tell us, by looking for one example country, the Republic of South Africa.
As we head into June, reports have continued to emerge that highlight the magnitude of the indirect effects the COVID-19 pandemic is having on health systems around the world. The pandemic has created additional barriers for patients accessing essential care, whether it be restrictions on movement, transportation restrictions, stigma, impoverishment from loss of livelihoods, or avoidance of care due to concerns over contracting the virus.
In stressing the high numbers of additional people who are dying as an indirect result of COVID-19 measures, we may have given the impression that we believe that there would be no additional non-COVID-19 deaths in an unmitigated scenario. We don’t believe that. We aimed to illustrate how the calculator works, and to demonstrate how users can adapt it to their own setting. The key to the tool is that each user is able to adapt it for their own setting.